by Written on behalf of Wise Health Law April 05, 2019 3 min read

All Regulated Health Professionals in Ontario Must Now Publicly Disclose Information

The Regulated Health Professions Act (“RHPA”) governs all regulated health professions in Ontario by establishing regulatory colleges, which provide oversight and guidance to each profession in service of the public interest. A new regulation to the RHPA (O.Reg. 261/18) came into force on May 1st, 2018, modifying the information required to be recorded in each professions’ public register per paragraph 19, subsection 23 (2) of the Health Professions Procedural Code (“HPPC”). The content of each register is governed by ss. 23(2) of the code. Paragraph 19 states that the register of each college must include information in accordance with regulations made under section 43(1) of the RHPA. O. Reg. 261/18 is such a regulation. The HPPC is deemed to be a part of each regulated health profession’s governing legislation.

What Kind of Information Must Now be Included?

  • The fact that a member has been charged with an offence under the Criminal Code of Canada ("CC") or the Controlled Drugs and Substances Act ("CDSA"), and if the charge is outstanding, the facts and contents with respect to the charge;
  • The fact that a member has been found guilty of a charge under the CC or the CDSA followed by a brief summary of the finding, the sentence and whether it is under appeal unless:
    • The Parole Board of Canada has ordered a record suspension in respect of the conviction;
    • A pardon in respect of the conviction has been obtained;
    • The conviction has been overturned on appeal;
  • The fact that a member has had any conditions of release imposed following a charge under the CC or the CDSA, or after a finding of guilt, and any appeal or subsequent variations of those conditions;
  • The fact that a member has been the subject of a disciplinary finding or a finding of professional misconduct or incompetence by another regulatory or licensing body in any jurisdiction, including the fact of the finding, the date, the jurisdiction and the existence and status of any appeal.

Mandatory Reporting

The RHPA requires members to self-report any findings of guilt made against them under the CC or the CDSA and as well any findings made against the member for professional negligence or malpractice. Members are also obligated to update their regulatory college if there are changes to their status following their initial report.

Registrar's Discretion

The Registrar of each college has some prescribed discretion about whether to record such information under section 23 of the HPPC. They can do so where they have reasonable grounds to believe that the disclosure may lead to harm for an individual or where the information is outdated and no longer relevant to the member's ability to practice. Reasonable grounds does not mean proof beyond a reasonable doubt, but rather that there is enough evidence to suggest that the conclusion reached is more likely than not.

Publication Bans

When publication bans are imposed in criminal trials, it is most often done to protect the victim(s). In such cases, the HPPC recognizes that such bans need to be respected despite the mandatory reporting requirements. Registrars must make enquiries to determine the purpose and scope of the publication ban before deciding what can, or should, be posted.

How an Experienced Health Law Lawyer Can Help

Obviously, members of the health professions will not likely be happy with the posting of these findings. There are means within the HPPC to have them removed under certain conditions as set out above. These steps will require legal assistance to ensure they are achieved and meet the statutory requirements for exclusion or expulsion. At Wise Health Law, we rely on our significant experience before discipline panels of various regulatory colleges to provide our clients with exceptional guidance and representation through the often-overwhelming discipline process. To find out more about how we can help, contact us online, or at 416-915-4234for a consultation.


Also in Blog

Cases to Watch: Marchi v. Nelson

by Mina Karabit September 22, 2020 3 min read

In August 2020, the Supreme Court heard and granted leave to appeal in Marchi v. Nelson, a case from the British Columbia Court of Appeal. The decision is one to watch as it will likely result in a renewed discussion of the distinction of policy versus operational decisions and their impacts on liability in tort law. The discussion will likely impact many of the anticipated post-COVID-19 lawsuits against public and government institutions.
Judicial Review: New Time Limits and a Helpful Primer

by Mina Karabit September 17, 2020 4 min read

In December 2019, Ontario’s Attorney General introduced Bill 161, the Smarter and Stronger Justice Act (the “Act”), which became law on July 8, 2020. The Act hopes to simplify a complex and outdated justice system by bringing changes to how legal aid services are delivered, how class actions are handled, and how court processes are administered.

Of note, the Act has amended the Judicial Review Procedures Act (JRPA) to establish new rules as to when an application for judicial review may be brought.

Any decisions made on or after July 8, 2020 are now subject to a 30-day limit for bringing an application for judicial review unless another Act provides otherwise. Courts, however, retain powers to extend the time for making an application for judicial review if satisfied that there are apparent grounds for relief and that no prejudice or hardship will be incurred by the delay. Before these amendments, the JRPA did not set out any time limits for bringing an application, but courts had powers to extend the time to bring an application if another Act prescribed the limit.

Recent Exemptions for Psychedelic Therapy in Canada

by Mina Karabit August 14, 2020 3 min read

In early August 2020, the Federal Minister of Health granted an exemption under the Controlled Drugs and Substances Act (CDSA) to four terminally ill Canadians to use psilocybin in their end of life care.

Psilocybin is one of the active ingredients/chemicals in “magic mushrooms,” the other is psilocin. Both psilocybin and psilocin are controlled substances under Schedule III of the CDSA. The sale, possession, production, etc. are prohibited unless authorized for clinical trial or research purposes under Part J of the Food and Drug Regulations. Both have been illegal in Canada since 1974. According to Health Canada, there are no approved therapeutic products containing psilocybin in Canada. However, the purified active ingredient, i.e. psilocybin, is being studied in supervised clinical settings for its potential to treat various conditions such as anxiety and depression.